作者: Debby Van Dam , Peter Paul De Deyn
DOI: 10.1111/J.1476-5381.2011.01299.X
关键词:
摘要: With increasing feasibility of predicting conversion of mild cognitive impairment to dementia based on biomarker profiling, the urgent need for efficacious disease‐modifying compounds …